Substitution as a Strategy to Improve Excipient Exposure in Neonates: One Piece of the Puzzle
- 82 Downloads
KeywordsPropylene Glycol Poloxamer Systematic Strategy Flexible Dose Saccharin Sodium
The clinical research of K Allegaert was supported by the Fund for Scientific Research, Flanders (fundamental clinical investigatorship 1800214N) and the research activities are further facilitated by the agency for innovation by Science and Technology in Flanders (IWT) through the SAFEPEDRUG project (IWT/SBO 130033).
Compliance with Ethical Standards
Conflict of interest
K. Allegaert and I. Spriet declare that they have no relevant conflicts of interest.
Source of funding
No sources of funding were used to support the writing of this manuscript.
- 4.Institute for Safe Medication Practices. Medication Safety Alert, February 13, 2014. Survey links PN component shortages to adverse outcomes. http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=70. Accessed 11 Apr 2016.
- 5.Klingmann V, Seitz A, Meissner T, Breitkreutz J, Moeltner A, Bosse HM. Acceptability of uncoated mini-tablets in neonates-a randomized controlled trial. J Pediatr. 2015;167:893–96e2.Google Scholar